reports
Vishay Precision Group Announces Date for Its Third Quarter Fiscal 202...
Vishay Precision Group Announces Date for Its Third Quarter Fiscal 2025 Earnings Conference Call MALVERN, Pa., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, will release its financial results for the third quarter fiscal 2025 before the opening of the market on Tuesday, November 4, 2025. Ziv Shoshani, chief executive officer, and Bill Clancy, chief financial officer, will host a conference call that day (Tuesday, November 4, 2025) at 9:00 a.m. U.S. eastern time. To access the conference call, intere...
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2...
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it will be presenting both an oral presentation and a poster on VP-315, its oncolytic peptide for the treatment of basal cell carcinoma (BCC), at the Society for Immu...
Dynamic Systems Inc. and Stony Brook University Announce Beta Trial of...
Dynamic Systems Inc. and Stony Brook University Announce Beta Trial of Ultra-High-Temperature Testing System for Advanced Materials Research POESTENKILL, N.Y., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Dynamic Systems Inc. (DSI), a subsidiary of Vishay Precision Group Inc. (NYSE: VPG), and Stony Brook University (SBU) announced today a beta evaluation of DSI’s Ultra High Temperature Ceramic and Composite (UHTC) testing system. The system enables the testing of ceramics and other non-conductive materials at temperatures exceeding 2000°C, providing researchers with new capabilities for studying th...
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Co...
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company – Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be held September 24, 2025 at 10:30 a.m. ET – CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. today announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology (“MIT”), securing the intellectual property that will serve as the cornerstone of its strategic relaunch. This agreement...
Verrica Pharmaceuticals Announces That Development Partner, Torii Phar...
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum – Approval triggers $10 million cash milestone payment to Verrica – – YCANTH® approval in Japan addresses significant unmet need of patients with molluscum – – Verrica maintains ownership of global rights to YCANTH for all indications in all territories outside of Japan – WEST CHESTER, Pa., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics co...
WillScot Announces Leadership Transition
WillScot Announces Leadership Transition President and COO Tim Boswell to Succeed Brad Soultz as Chief Executive Officer Worthing Jackman, Chairman of the Board, Named Executive Chairman of the Board Jeff Sagansky Appointed Lead Independent Director PHOENIX, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that the Company’s Board of Directors (the “Board”) has unanimously elected Tim Boswell to succeed Brad Soultz as Chief Executive Officer, effective Ja...
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Ann...
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference WEST CHESTER, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York City. H.C. Wainwright 27th Annual Global Investment Confer...
WillScot Holdings Corp: 1 director
A director at WillScot Holdings Corp sold 22,000 shares at 24.630USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results – Company reports $12.7 million in revenue in Q2’25, consisting primarily of $4.5 million in YCANTH® revenue, net, reflecting sequential growth of 32.5% over Q1’25 and $8.0 million in milestone revenue from Torii Pharmaceutical – – Completed Successful End of Phase 2 Meeting for VP-315 for Basal Cell Carcinoma; Company is preparing for the Phase 3 program and exploring non-dilutive opportunities for financing further development – – Conference call scheduled for today at 4:30 pm ET – WEST CHESTER, Pa., Aug. ...
VPG to Present at Upcoming Investor Conferences on August 27, 2025, in...
VPG to Present at Upcoming Investor Conferences on August 27, 2025, in Chicago, IL and September 3, 2025, in New York, NY MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, will present at the following investor conferences: 16th Annual Midwest IDEAS Conference on Wednesday, August 27, 2025, at the InterContinental Chicago Magnificent Mile, Chicago, IL. The company’s presentation is scheduled to begin at 4:30 p.m. ET (3:30 p.m. CT). A live and on-demand webcast of VPG’s presentation...
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Result...
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025 WEST CHESTER, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on Tuesday, August 12, 2025, to discuss the Company's financial results for the second quarter ending June 30, 2025, and provide a corporate update. In...
VPG Reports Fiscal 2025 Second Quarter Results
VPG Reports Fiscal 2025 Second Quarter Results MALVERN, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced its results for its fiscal 2025 second quarter ended June 28, 2025. Second Fiscal Quarter Highlights (comparisons are to the comparable period a year ago): Net revenues of $75.2 million decreased 2.8%.Gross profit margin was 40.7% as compared to 41.9%Adjusted gross profit margin* was 41.0%, as compared to 41.9%Operating margin was 3.6% as compared to 7.6%.Adjusted operating mar...
WillScot Reports Second Quarter 2025 Results and Updates 2025 Full Yea...
WillScot Reports Second Quarter 2025 Results and Updates 2025 Full Year Outlook PHOENIX, July 31, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced second quarter 2025 results, including key performance highlights, market updates, and narrowed its original 2025 full year outlook. Q2 20251, 2 Generated revenue of $589 million, gross profit margin percentage of 50.3%, net income of $48 million, and diluted earnings per share of $0.26.Leasing revenues of $...
WillScot Declares Quarterly Cash Dividend
WillScot Declares Quarterly Cash Dividend PHOENIX, July 31, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its Board of Directors has declared a quarterly dividend of $0.07 per common share. The cash dividend will be paid on September 17, 2025, to shareholders of record as of the close of business on September 3, 2025. About WillScot Listed on the Nasdaq stock exchange under the ticker symbol “WSC,” WillScot is the premier provider of highly innovative and turnkey ...
Vishay Precision Group Announces Date for Its Second Quarter Fiscal 20...
Vishay Precision Group Announces Date for Its Second Quarter Fiscal 2025 Earnings Conference Call MALVERN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, will release its financial results for the second quarter fiscal 2025 before the opening of the market on Tuesday, August 5, 2025. Ziv Shoshani, chief executive officer, and Bill Clancy, chief financial officer, will host a conference call that day (Tuesday, August 5, 2025) at 9:00 a.m. U.S. eastern time. To access the conference call, intere...
WillScot to Announce Second Quarter 2025 Results on July 31, 2025
WillScot to Announce Second Quarter 2025 Results on July 31, 2025 PHOENIX, July 15, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will release its second quarter 2025 financial results on July 31, 2025, after market close. The Company’s management team will host a conference call and webcast on July 31, 2025, at 5:30 p.m. EDT to discuss the Company’s results. To access the live call by phone, use the following link by clicking to obtain registrati...
Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed App...
Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 – Company reports sequential quarterly growth of 32.8% over Q1 2025 with a record 13,434 YCANTH® dispensed applicator units in Q2 2025 – – Company reports receipt of $8 million milestone payment from its Japanese development partner, Torii Pharmaceutical, for initiation of global Phase 3 program in common warts – WEST CHESTER, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medica...
Verrica Pharmaceuticals Announces Amendment to Collaboration and Licen...
Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts – Verrica to receive a $8 million milestone payment for initiation of the global study in July 2025, ahead of previous schedule – – Verrica to receive a $10 million milestone payment from Torii in cash upon the approval of YCANTH® (TO-208 in Japan) for molluscum contagiosum in Japan; approval decision expected by the end of 2025 – – Torii to fund the first $40 million of out-of-pocket...
WillScot Named as Presenting Sponsor of Borchetta Bourbon Music City G...
WillScot Named as Presenting Sponsor of Borchetta Bourbon Music City Grand Prix in Partnership with Penske Entertainment Corp. PHOENIX, June 26, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), North America’s leading provider of temporary space solutions, announced its support of the Borchetta Bourbon Music City Grand Prix as a presenting sponsor of the upcoming event, in partnership with Penske Entertainment Corp. Tim Boswell, President and Chief Operating Officer, commented, “As a leading provider of complete, turnkey space solutions ...
WillScot Introduces Innovative Power Solution – Solar Power by WillSco...
WillScot Introduces Innovative Power Solution – Solar Power by WillScot PHOENIX, June 04, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, announced Solar Power by WillScot, a proprietary power solution that redefines how energy is delivered —bringing clean, reliable power to virtually any site, and unlocking new possibilities for how and where people work. was designed to provide immediate energy production and battery storage wherever WillScot’s temporary space solutions are deployed. A...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.